WallStreetZenWallStreetZen
Analyst Ranking
Top 45%
#1901 out of 4227 analysts
Average Return
+0.12%
Win Rate
40%14 out of 35
Risk vs Reward
Poor
Good

Robert Wasserman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Molekule Group IncMKUL
+174.00%$5.00$13.70
2022-01-31 -
2022-06-14
Buy
Ligand Pharmaceuticals IncLGND
+119.54%$92.48$203.03
2020-02-05 -
2021-02-05
Strong Buy
Halozyme Therapeutics IncHALO
+69.20%$27.40$46.36
2020-06-30 -
2021-07-01
Strong Buy
Bio Techne CorpTECH
+53.17%$65.51$100.34
2020-05-13 -
2021-05-14
Strong Buy
Integer Holdings CorpITGR
+30.62%$71.66$93.60
2020-05-13 -
2021-05-14
Strong Buy

Robert Wasserman Analyst Color

Get additional color on Robert Wasserman's coverage of popular stocks

Robert Wasserman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Proto Labs IncPRLB
5Strong Buy$45.00+41.82%Reiterates
2 days ago
Molekule Group IncMKUL
4Buy$7.00+270.37%Reiterates
5 days ago
Emergent Biosolutions IncEBS
5Strong Buy$22.00+169.28%Reiterates
9 days ago
Anebulo Pharmaceuticals IncANEB
3Buy$8.00+236.13%Reiterates
10 days ago
Omniab IncOABI
2Strong Buy$8.00+88.24%Reiterates
16 days ago
Codexis IncCDXS
1Strong Buy$9.00+264.37%Maintains
19 days ago
Fortress Biotech IncFBIO
2Buy$5.00+810.75%Reiterates
2 months ago
Repligen CorpRGEN
1Strong Buy$230.00+34.49%Initiates Coverage On
2 months ago
Immunoprecise Antibodies LtdIPA
2Buy$7.00+153.16%Maintains
2 months ago
Ligand Pharmaceuticals IncLGND
3Strong Buy$95.00+31.71%Reiterates
3 months ago
Bio Techne CorpTECH
2Strong Buy$120.00+43.71%Maintains
4 months ago
Halozyme Therapeutics IncHALO
2Strong Buy$68.00+104.82%Maintains
6 months ago
Danaher CorpDHR
3HoldN/AN/ADowngrades
7 months ago
Abcellera Biologics IncABCL
1Strong Buy$27.00N/AInitiates Coverage On
a year ago
Thermo Fisher Scientific IncTMO
1Strong Buy$580.00N/AInitiates Coverage On
2 years ago
Biolife Solutions IncBLFS
2Strong Buy$54.00N/AUpgrades
2 years ago
Integer Holdings CorpITGR
1Strong Buy$105.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.